311 related articles for article (PubMed ID: 31469467)
1. Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk.
Harris KL; Myers MB; McKim KL; Elespuru RK; Parsons BL
Environ Mol Mutagen; 2020 Jan; 61(1):152-175. PubMed ID: 31469467
[TBL] [Abstract][Full Text] [Related]
2. Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas.
Parsons BL; McKim KL; Myers MB
Environ Mol Mutagen; 2017 Aug; 58(7):466-476. PubMed ID: 28755461
[TBL] [Abstract][Full Text] [Related]
3. Quantification of cancer driver mutations in human breast and lung DNA using targeted, error-corrected CarcSeq.
Harris KL; Walia V; Gong B; McKim KL; Myers MB; Xu J; Parsons BL
Environ Mol Mutagen; 2020 Nov; 61(9):872-889. PubMed ID: 32940377
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Genotoxicology: Using Modern Sequencing Technologies to Assess Somatic Mutagenesis and Cancer Risk.
Salk JJ; Kennedy SR
Environ Mol Mutagen; 2020 Jan; 61(1):135-151. PubMed ID: 31595553
[TBL] [Abstract][Full Text] [Related]
5. Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.
Tokheim C; Bhattacharya R; Niknafs N; Gygax DM; Kim R; Ryan M; Masica DL; Karchin R
Cancer Res; 2016 Jul; 76(13):3719-31. PubMed ID: 27197156
[TBL] [Abstract][Full Text] [Related]
6. Direct quantification of in vivo mutagenesis and carcinogenesis using duplex sequencing.
Valentine CC; Young RR; Fielden MR; Kulkarni R; Williams LN; Li T; Minocherhomji S; Salk JJ
Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33414-33425. PubMed ID: 33318186
[TBL] [Abstract][Full Text] [Related]
7. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
8. An analysis of mutational signatures of synonymous mutations across 15 cancer types.
Bin Y; Wang X; Zhao L; Wen P; Xia J
BMC Med Genet; 2019 Dec; 20(Suppl 2):190. PubMed ID: 31815613
[TBL] [Abstract][Full Text] [Related]
9. Lifespan Kras mutation levels in lung and liver of B6C3F
McKinzie PB; McKim KL; Pearce MG; Bishop ME; Parsons BL
Environ Mol Mutagen; 2018 Oct; 59(8):715-721. PubMed ID: 30255594
[TBL] [Abstract][Full Text] [Related]
10. Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
Chen T; Wang Z; Zhou W; Chong Z; Meric-Bernstam F; Mills GB; Chen K
BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):394. PubMed ID: 27356755
[TBL] [Abstract][Full Text] [Related]
11. Rational design of cancer gene panels with OncoPaD.
Rubio-Perez C; Deu-Pons J; Tamborero D; Lopez-Bigas N; Gonzalez-Perez A
Genome Med; 2016 Oct; 8(1):98. PubMed ID: 27716338
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia.
Harris KL; McKim KL; Myers MB; Gong B; Xu J; Parsons BL
Toxicol Sci; 2021 Oct; 184(1):1-14. PubMed ID: 34373914
[TBL] [Abstract][Full Text] [Related]
13. Environmental Carcinogenesis and Transgenerational Transmission of Carcinogenic Risk: From Genetics to Epigenetics.
Burgio E; Piscitelli P; Colao A
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30127322
[TBL] [Abstract][Full Text] [Related]
14. A Collaborative Initiative to Establish Genomic Biomarkers for Assessing Tumorigenic Potential to Reduce Reliance on Conventional Rodent Carcinogenicity Studies.
Corton JC; Mitchell CA; Auerbach S; Bushel P; Ellinger-Ziegelbauer H; Escobar PA; Froetschl R; Harrill AH; Johnson K; Klaunig JE; Pandiri AR; Podtelezhnikov AA; Rager JE; Tanis KQ; van der Laan JW; Vespa A; Yauk CL; Pettit SD; Sistare FD
Toxicol Sci; 2022 Jun; 188(1):4-16. PubMed ID: 35404422
[TBL] [Abstract][Full Text] [Related]
15. Filling the gap between risk assessment and molecular determinants of tumor onset.
Chiara F; Indraccolo S; Trevisan A
Carcinogenesis; 2021 Apr; 42(4):507-516. PubMed ID: 33319226
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Mutations but No Cancer: Insights into the Early Steps of Carcinogenesis and Implications for Early Cancer Detection.
Kennedy SR; Zhang Y; Risques RA
Trends Cancer; 2019 Sep; 5(9):531-540. PubMed ID: 31474358
[TBL] [Abstract][Full Text] [Related]
17. Error-corrected next generation sequencing - Promises and challenges for genotoxicity and cancer risk assessment.
Marchetti F; Cardoso R; Chen CL; Douglas GR; Elloway J; Escobar PA; Harper T; Heflich RH; Kidd D; Lynch AM; Myers MB; Parsons BL; Salk JJ; Settivari RS; Smith-Roe SL; Witt KL; Yauk CL; Young R; Zhang S; Minocherhomji S
Mutat Res Rev Mutat Res; 2023; 792():108466. PubMed ID: 37643677
[TBL] [Abstract][Full Text] [Related]
18. CarcSeq Measurement of Rat Mammary Cancer Driver Mutations and Relation to Spontaneous Mammary Neoplasia.
McKim KL; Myers MB; Harris KL; Gong B; Xu J; Parsons BL
Toxicol Sci; 2021 Jul; 182(1):142-158. PubMed ID: 33822199
[TBL] [Abstract][Full Text] [Related]
19. Performance characteristics of the AmpliSeq Cancer Hotspot panel v2 in combination with the Ion Torrent Next Generation Sequencing Personal Genome Machine.
Butler KS; Young MY; Li Z; Elespuru RK; Wood SC
Regul Toxicol Pharmacol; 2016 Feb; 74():178-86. PubMed ID: 26387931
[TBL] [Abstract][Full Text] [Related]
20. Passenger Hotspot Mutations in Cancer.
Hess JM; Bernards A; Kim J; Miller M; Taylor-Weiner A; Haradhvala NJ; Lawrence MS; Getz G
Cancer Cell; 2019 Sep; 36(3):288-301.e14. PubMed ID: 31526759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
